1. Home
  2. IOVA vs PCTY Comparison

IOVA vs PCTY Comparison

Compare IOVA & PCTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$14.11

Market Cap

6.7B

Sector

Health Care

ML Signal

HOLD

Logo Paylocity Holding Corporation

PCTY

Paylocity Holding Corporation

HOLD

Current Price

$177.56

Market Cap

7.8B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
IOVA
PCTY
Founded
2007
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
6.7B
7.8B
IPO Year
2008
2014

Fundamental Metrics

Financial Performance
Metric
IOVA
PCTY
Price
$14.11
$177.56
Analyst Decision
Buy
Strong Buy
Analyst Count
10
21
Target Price
$14.40
★ $172.60
AVG Volume (30 Days)
★ 12.5M
534.8K
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
14.84
★ 22.39
EPS
N/A
★ 4.92
Revenue
N/A
★ $1,771,326,000.00
Revenue This Year
$56.63
$6.93
Revenue Next Year
$42.41
$7.86
P/E Ratio
★ N/A
$34.50
Revenue Growth
N/A
★ 11.04
52 Week Low
$1.76
$92.99
52 Week High
$15.37
$171.81

Technical Indicators

Market Signals
Indicator
IOVA
PCTY
Relative Strength Index (RSI) 59.41 82.68
Support Level $3.57 $139.25
Resistance Level $15.00 N/A
Average True Range (ATR) 0.92 3.82
MACD -0.17 2.34
Stochastic Oscillator 58.17 99.03

Price Performance

Historical Comparison
IOVA
PCTY

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

About PCTY Paylocity Holding Corporation

Paylocity is a cloud-based human capital management provider offering payroll, compliance, and human resources management solutions. With the addition of expense and IT management modules, Paylocity unifies back-office operations spanning HR, finance, and IT on a single platform and bills customers on a subscription basis. The firm's customer base skews toward the midmarket and is primarily based in the US. As of fiscal 2026, Paylocity has nearly 44,400 customers.

Share on Social Networks: